InMed Pharmaceuticals's total assets for Q2 2025 were $8.50M, a decrease of -18.76% from the previous quarter. INM total liabilities were $2.32M for the fiscal quarter, a -99.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.